| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 74206 |
cas:2054345-67-2，azido-tris(ethylenoxy)-L-alanine TFA Salt化学性质 |
83 |
zyl |
2024-12-19 |
| 74207 |
cas:68617-64-1，SPDP acid，3-(2-吡啶二硫代)丙酸的合成方法 |
119 |
zyl |
2024-12-19 |
| 74208 |
1,4,7,10-四(羧甲基)-1,4,7,10-四氮杂环十二烷单酰胺偶联葡萄糖 |
84 |
h |
2024-12-19 |
| 74209 |
PEG-P(Asp-Gd-DOTA)Gd‐DOTA偶联聚乙二醇改性聚天冬氨酸 |
89 |
h |
2024-12-19 |
| 74210 |
cas:70539-42-3，EGS Crosslinker，乙二醇-双(琥珀酸N-羟基琥珀酰亚胺酯)的结构式 |
137 |
zyl |
2024-12-19 |
| 74211 |
CXCR4导向的五肽[(68)Ga]喷替沙福(环(-D-Tyr-N-Me-D-Orn(AMB-DOTA)-L-Arg-L-2-Nal-Gly-)) |
116 |
h |
2024-12-19 |
| 74212 |
α-hexadecyl-DOTA α-十六烷基-DOTA |
83 |
h |
2024-12-19 |
| 74213 |
Methyltetrazine-SS-NHS 甲基四唑-双硫键-活性酯的合成方法 |
75 |
zyl |
2024-12-19 |
| 74214 |
DOTA-AgRP-6E |
110 |
h |
2024-12-19 |
| 74215 |
DOTA-morab-003 DOTA偶联单克隆抗体MORAb-003 |
73 |
h |
2024-12-19 |
| 74216 |
DOTA-Bz-folate DOTA-Bz-叶酸 |
91 |
h |
2024-12-19 |
| 74217 |
cas:55750-53-3，6-Maleimidocaproic acid，6-马来酰亚氨基己酸 |
102 |
zyl |
2024-12-19 |
| 74218 |
cas: Fmoc-PEG3-Val-Cit，ADC定制 |
80 |
wyh |
2024-12-19 |
| 74219 |
钆(III)DOTA-DSPE脂质体 |
78 |
h |
2024-12-19 |
| 74220 |
CAS: 870487-08-4，Boc-Val-Cit，叔丁氧羰基-缬氨酰-L-瓜氨酸 |
70 |
WYQ |
2024-12-19 |
| 74221 |
DOTA-Phe-D-Trp-Lys-Thr-OMe DOTA偶联生长抑素四肽类似物 |
102 |
h |
2024-12-19 |
| 74222 |
CAS: 35665-38-4，Fmoc-Gly-Gly-OH，Fmoc-甘氨酰-甘氨酸 |
104 |
WYQ |
2024-12-19 |
| 74223 |
cas:117235-10-6，3-Mercaptopropanyl-N-hydroxysuccinimide ester的结构式 |
102 |
zyl |
2024-12-19 |
| 74224 |
DOTA-PEG(4)-BBN(7-14)-AuNP DOTA-神经介素n功能化NHS活化的PEG-金纳米颗粒 |
72 |
h |
2024-12-19 |
| 74225 |
cas:2226472-28-0，DBCO-PEG4-Val-Cit-PAB-PNP，ADC定制 |
64 |
wyh |
2024-12-19 |
| 74226 |
CAS: 863971-53-3，Fmoc-Val-Cit-PAB-PNP |
83 |
WYQ |
2024-12-19 |
| 74227 |
tris-苄基-DOTA tris-benzyl-DOTA |
103 |
h |
2024-12-19 |
| 74228 |
DOTA-DN(PTX)-BN DOTA-铃蟾肽功能化聚酰胺胺(PAMAM)树状大分子(DN)负载紫杉醇 |
90 |
h |
2024-12-19 |
| 74229 |
NH2-Sar10-COOH，ADC定制 |
73 |
wyh |
2024-12-19 |
| 74230 |
cas:1415328-95-8，NHPI-PEG4-C2-NHS ester |
91 |
zyl |
2024-12-19 |
| 74231 |
Gd-GlyMe-DOTA-全氟辛基甘露糖缀合物(Gadofluorine M) |
127 |
h |
2024-12-19 |
| 74232 |
MC-Val-Cit-PAB-PNP（CAS号：159857-81-5） |
113 |
WYQ |
2024-12-19 |
| 74233 |
Mal-Gly-Gly-L-Phe-N-[(carboxymethoxy)methyl]Glycinamide，ADC定制 |
82 |
wyh |
2024-12-19 |
| 74234 |
L-RNA寡核苷酸的功能化DOTA |
91 |
h |
2024-12-19 |
| 74235 |
MA-PEG4-Glu(t-Bu)-Val-Cit-PAB-PNP，在药物递送系统中具有广泛应用潜力 |
77 |
WYQ |
2024-12-19 |
| 74236 |
cas:1415800-42-8，perfluorophenyl 1-(2,5-dioxo-2H-pyrrol-1(5H)-yl)-3,6,9,12-tetraoxapentadecan-15-oate |
66 |
zyl |
2024-12-19 |
| 74237 |
羟基磺基琥珀酰亚胺DOTA(DOTA-OSSu) |
110 |
h |
2024-12-19 |
| 74238 |
Mal-PEG1-Val-Cit-OH，生物化学和药物研发领域有潜在应用 |
84 |
WYQ |
2024-12-19 |
| 74239 |
cas:1193111-39-5，1-(2,5-dioxopyrrolidin-1-yloxy)-1-oxo-4-(pyridin-2-yldisulfanyl)butane-2-sulfonic acid |
77 |
zyl |
2024-12-19 |
| 74240 |
DOTA-GGG-BN(7-14) |
80 |
h |
2024-12-19 |
| 74241 |
CAS: 108-30-5，Dihydrofuran-2,5-dione（丁二酸酐） |
102 |
WYQ |
2024-12-19 |
| 74242 |
cas:1884578-00-0 Boc-Val-Ala-PAB-PNP |
90 |
zyl |
2024-12-19 |
| 74243 |
DOTA-L22-异硫氰酸荧光素-依沙酸 |
77 |
h |
2024-12-19 |
| 74244 |
cas:2768446-73-5 DBCO-Val-Cit-PAB-MMAE |
72 |
zyl |
2024-12-19 |
| 74245 |
Boc-PEG4-Val-Ala-PAB，ADC定制 |
81 |
wyh |
2024-12-19 |
| 74246 |
CAS: 2504147-59-3，MC (C5)-Val-Cit |
67 |
WYQ |
2024-12-19 |
| 74247 |
CAS: 159857-80-4，MC-Val-Cit-PAB-OH |
81 |
WYQ |
2024-12-19 |
| 74248 |
cas:2055024-65-0 Azido-PEG3-Val-Cit-PAB-OH |
82 |
zyl |
2024-12-19 |
| 74249 |
Mal-Amide-PEG4-Val-Cit-PAB-OH，ADC定制 |
63 |
wyh |
2024-12-19 |
| 74250 |
CAS 2249935-92-8：Mal-PEG1-Val-Cit-PAB-PNP |
89 |
WYQ |
2024-12-19 |
齐岳微信公众号
官方微信
库存查询